Skip to Main Content
Advertisement
Close
AACR Journals
Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics
For Authors
Information for Authors
Author Services
Journal Awards
Best of: Author Profiles
About Us
AACR Journals
Advertising
Permissions & Reprints
Subscriptions
Submit
Article Collections
Journal Collections
Hot Topics
'Best Of' Collection
Editors' Picks
COVID-19
Webinars
Search Dropdown Menu
header search
search input
Search input auto suggest
Search
Advanced Search
User Tools Dropdown
Register
Sign In
Toggle Menu
Menu
About
The Journal
AACR Journals
Subscriptions
Permissions and Reprints
Articles
Online First
Issues
CCR Focus Archives
Meeting Abstracts
Collection: Clinical Trials 2022
Collection: Sarcoma
Collection: Lymphoma
Collection: Breast Cancer
Collection: Clinical Trials
Collection: Immunotherapy: Facts and Hopes
Collection: Editors' Picks
Collection: 'Best 'Of' Collection
For Authors
Information for Authors
Author Services
Best of: Author Profiles
Submit
Alerts
News
COVID-19
Webinars
Skip Nav Destination
Issues
Select Year
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
Issue
1 January - Volume 24, Issue 1, Pages 1 - 250
1 January - Volume 24, Issue 1_Supplement
15 January - Volume 24, Issue 2, Pages 251 - 501
15 January - Volume 24, Issue 2_Supplement
1 February - Volume 24, Issue 3, Pages 503 - 724
15 February - Volume 24, Issue 4, Pages 725 - 985
1 March - Volume 24, Issue 5, Pages 987 - 1239
15 March - Volume 24, Issue 6, Pages 1241 - 1510
1 April - Volume 24, Issue 7, Pages 1511 - 1770
15 April - Volume 24, Issue 8, Pages 1771 - 2025
1 May - Volume 24, Issue 9, Pages 2027 - 2234
15 May - Volume 24, Issue 10, Pages 2235 - 2463
1 June - Volume 24, Issue 11, Pages 2465 - 2709
15 June - Volume 24, Issue 12, Pages 2711 - 2976
1 July - Volume 24, Issue 13, Pages 2977 - 3229
15 July - Volume 24, Issue 14, Pages 3231 - 3474
1 August - Volume 24, Issue 15, Pages 3475 - 3783
1 August - Volume 24, Issue 15_Supplement
15 August - Volume 24, Issue 16, Pages 3785 - 4055
1 September - Volume 24, Issue 17, Pages 4057 - 4347
1 September - Volume 24, Issue 17_Supplement
15 September - Volume 24, Issue 18, Pages 4349 - 4626
1 October - Volume 24, Issue 19, Pages 4627 - 4912
15 October - Volume 24, Issue 20, Pages 4913 - 5189
1 November - Volume 24, Issue 21, Pages 5191 - 5489
15 November - Volume 24, Issue 22, Pages 5491 - 5783
1 December - Volume 24, Issue 23, Pages 5785 - 6103
15 December - Volume 24, Issue 24, Pages 6105 - 6612
Volume 24, Issue 15_Supplement
1 August 2018
ISSN 1078-0432
EISSN 1557-3265
Close mobile search navigation
In this Issue
DNA Damage and Repair
Drug Response and Resistance to Therapy
Exploiting Vulnerabilities in Rare Tumors
Genetics and Molecular Drivers
Immunotherapy
Metabolic Changes in Ovarian Cancer
Prevention and Early Detection
Tumor Microenvironment
Other Topics
Issue Navigation
Search within issue:
Search within issue
Abstracts: AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; October 1-4, 2017; Pittsburgh, PA
DNA Damage and Repair
Drug Response and Resistance to Therapy
Exploiting Vulnerabilities in Rare Tumors
Genetics and Molecular Drivers
Immunotherapy
Metabolic Changes in Ovarian Cancer
Prevention and Early Detection
Tumor Microenvironment
Other Topics
All Issues
Advertisement
Email alerts
Online First Alert
eTOC Alert
Close Modal
Latest
Most Read
Most Cited
A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer
The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer
Systemic and oligo-acquired resistance to PD-(L)1 blockade in lung cancer
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to
our privacy policy.
Accept
